Department of Radiation Oncology, Tata Medical Center, Newtown, Kolkata, West Bengal.
Department of Radiation Oncology, Tata Medical Center, Newtown, Kolkata, West Bengal.
Pract Radiat Oncol. 2018 Nov-Dec;8(6):382-387. doi: 10.1016/j.prro.2018.03.007. Epub 2018 Mar 21.
Use of deep inspiration breath hold (DIBH) radiation therapy may reduce long-term cardiac mortality. The resource and time commitments associated with DIBH are impediments to its widespread adoption. We report the dosimetric benefits, workforce requirements, and potential reduction in cardiac mortality when DIBH is used for left-sided breast cancers.
Data regarding the time consumed for planning and treating 50 patients with left-sided breast cancer with DIBH and 20 patients treated with free breathing (FB) radiation therapy were compiled prospectively for all personnel (regarding person-hours [PH]). A second plan was generated for all DIBH patients in the FB planning scan, which was then compared with the DIBH plan. Mortality reduction from use of DIBH was calculated using the years of life lost resulting from ischemic heart disease for Indians and the postulated reduction in risk of major cardiac events resulting from reduced cardiac dose.
The median reduction in mean heart dose between the DIBH and FB plans was 166.7 cGy (interquartile range, 62.7-257.4). An extra 6.76 PH were required when implementing DIBH as compared with FB treatments. Approximately 3.57 PH were necessary per Gy of reduction in mean heart dose. The excess years of life lost from ischemic heart disease if DIBH was not done in was 0.95 per 100 patients, which translates into a saving of 12.8 hours of life saved per PH of work required for implementing DIBH. DIBH was cost effective with cost for implementation of DIBH for all left-sided breast cancers at 2.3 times the annual per capita gross domestic product.
Although routine implementation of DIBH requires significant resource commitments, it seems to be worthwhile regarding the projected reductions in cardiac mortality.
使用深吸气屏气(DIBH)放射治疗可能会降低长期的心脏死亡率。DIBH 的资源和时间投入是其广泛应用的障碍。我们报告了在左侧乳腺癌中使用 DIBH 的剂量学优势、劳动力需求以及潜在的心脏死亡率降低。
前瞻性地收集了 50 例左侧乳腺癌 DIBH 计划和 20 例自由呼吸(FB)放疗患者的计划和治疗时间数据,以评估所有人员(关于人时[PH])的工作量。在 FB 计划扫描中为所有 DIBH 患者生成了第二个计划,并将其与 DIBH 计划进行比较。使用印度人缺血性心脏病导致的生命损失年数和由于心脏剂量减少导致的主要心脏事件风险降低的假设来计算使用 DIBH 降低死亡率。
DIBH 与 FB 计划之间平均心脏剂量的中位数降低了 166.7 cGy(四分位距,62.7-257.4)。与 FB 治疗相比,实施 DIBH 时需要额外的 6.76 PH。平均心脏剂量每降低 1 Gy,需要额外 3.57 PH。如果不进行 DIBH,缺血性心脏病导致的生命损失年数为 0.95 年/每 100 例患者,这相当于实施 DIBH 所需的每 PH 工作时间节省 12.8 小时的生命。DIBH 是具有成本效益的,对于所有左侧乳腺癌,DIBH 的实施成本是人均国内生产总值的 2.3 倍。
尽管常规实施 DIBH 需要大量的资源投入,但考虑到心脏死亡率的预计降低,它似乎是值得的。